Comparative proteomic analysis of osteosarcoma cell and human primary cultured osteoblastic cell

Cancer Investigation

Volumn 27, Issue 3, 2009, Pages 345-352

  Liu, Xudong ^a   Zeng, Bingfang ^a   Ma, Jie ^a,b   Wan, Chunling ^a  

^a SHANGHAI JIAO TONG UNIVERSITY   (China)

^b MEDICAL SCHOOL OF XI AN JIAOTONG UNIVERSITY   (China)

Author keywords

Biomarker; Osteosarcoma; Proteome

Indexed keywords

ACTIN CAPPING PROTEIN; HEAT SHOCK PROTEIN 70; LIPOCORTIN 5; MTHSP75 PROTEIN; NUCLEAR PROTEIN; PRDX4 PROTEIN; PROHIBITIN; PROTEIN; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATE SYNTHASE; PYRUVATE DEHYDROGENASE E1; PYRUVIC ACID DERIVATIVE; RAN PROTEIN; SILVER; UCH L1 PROTEIN; UNCLASSIFIED DRUG; UQCRC1 PROTEIN; PEROXIREDOXIN; PRDX4 PROTEIN, HUMAN; PROTEOME; PROTON TRANSPORTING ADENOSINE TRIPHOSPHATASE; TUMOR PROTEIN; UBIQUITIN THIOLESTERASE; UCHL1 PROTEIN, HUMAN;

ADOLESCENT; ADULT; ARTICLE; CANCER TISSUE; CHILD; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN CELL; HUMAN CELL CULTURE; HUMAN TISSUE; IMAGE ANALYSIS; MALE; MASS SPECTROMETRY; OSTEOBLAST; OSTEOSARCOMA; OSTEOSARCOMA CELL; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN VARIANT; PROTEOMICS; SCHOOL CHILD; WESTERN BLOTTING; BONE TUMOR; CELL CULTURE; CHEMISTRY; COMPARATIVE STUDY; TWO DIMENSIONAL GEL ELECTROPHORESIS;

BLOTTING, WESTERN; BONE NEOPLASMS; CELLS, CULTURED; ELECTROPHORESIS, GEL, TWO-DIMENSIONAL; HSP70 HEAT-SHOCK PROTEINS; HUMANS; NEOPLASM PROTEINS; OSTEOBLASTS; OSTEOSARCOMA; PEROXIREDOXINS; PROTEOME; PROTON-TRANSLOCATING ATPASES; SPECTROMETRY, MASS, MATRIX-ASSISTED LASER DESORPTION-IONIZATION; UBIQUITIN THIOLESTERASE;

EID: 63349090970     PISSN: 07357907     EISSN: 15324192     Source Type: Journal    
DOI: 10.1080/07357900802438577     Document Type: Article

References (29)

1. Ferguson, W.S.; Goorin, A.M. Current treatment of osteosarcoma. Cancer Invest 2001, 19(3), 292-315.
2. Fuchs, B.; Zhang, K.; Schabel, A.; Bolander, M.E.; Sarkar, G. Identification of twenty-two candidate markers for human osteogenic sarcoma. Gene 2001, 278(1-2), 245-252. (Pubitemid 33055799)
3. Tsai, J.Y.; Aviv, H.; Benevenia, J.; Chang, V.T.; Patterson, F.; Aisner, S.; Hameed, M. HER-2/neu and p53 in osteosarcoma: an immunohistochemical and fluorescence in situ hybridization analysis. Cancer Invest 2004, 22(1), 16-24. (Pubitemid 38523956)
4. Trieb, K.; Lehner, R.; Stulnig, T.; Sulzbacher, I.; Shroyer, K.R. Survivin expression in human osteosarcoma is a marker for survival. Eur J Surg Oncol 2003, 29(4), 379-382. (Pubitemid 36675696)
5. Alaiya, A.; Al-Mohanna, M.; Linder, S. Clinical cancer proteomics: promises and pitfalls. J Proteome Res 2005, 4(4), 1213-1222. (Pubitemid 41213336)
6. Wolf, M.; El-Rifai, W.; Tarkkanen, M.; Kononen, J.; Serra, M.; Eriksen, E.F.; Elomaa, I.; Kallioniemi, A.; Kallioniemi, O.P.; Knuutila, S. Novel findings in gene expression detected in human osteosarcoma by cDNA microarray. Cancer Genet Cytogenet 2000, 123(2), 128-132. (Pubitemid 32012494)
7. Atiye, J.; Wolf, M.; Kaur, S.; Monni, O.; Böhling, T.; Kivioja, A.; Tas, E.; Serra, M.; Tarkkanen, M.; Knuutila, S. Gene amplifications in osteosarcoma-CGH microarray analysis. Genes Chromosomes Cancer 2005, 42(2), 158-163. (Pubitemid 40094099)
8. Guo, Q.C.; Shen, J.N.; Jin, S.; Wang, J.; Huang, G.; Zhang, L.J.; Huang, G.; Yin, J.Q.; Zou, C.Y.; Li, M.T. Comparative proteomic analysis of human osteosarcoma and SV40-immortalized normal osteoblastic cell lines. Acta Pharmacol Sin 2007, 28(6), 850-858. (Pubitemid 46817447)
9. Walsh, C.A.; Birch, M.A.; Fraser, W.D.; Lawton, R.; Dorgan, J.; Walsh, S.; Sansom, D.; Beresford, J.N.; Gallagher, J.A. Expression and secretion of parathyroid hormone-related protein by human bone-derived cells in vitro: effects of glucocorticoids. J Bone Miner Res 1995, 10(1), 17-25.
10. Frediani, B.; Spreafico, A.; Capperucci, C.; Chellini, F.; Gambera, D.; Ferrata, P.; Baldi, F.; Falsetti, P.; Santucci, A.; Bocchi, L.; Marcolongo, R. Long-term effects of neridronate on human osteoblastic cell cultures. Bone 2004, 35(4), 859-869. (Pubitemid 39349217)
11. Liu, X.D.; Zeng, B.F.; Xu, J.G.; Zhu, H.B.; Xia, Q.C. Proteomic analysis of the cerebrospinal fluid of patients with lumbar disk herniation. Proteomics 2006, 6(3), 1019-1028. (Pubitemid 43260226)
12. Garrido, C.; Brunet, M.; Didelot, C.; Zermati, Y.; Schmitt, E.; Kroemer, G.. Heat shock proteins 27 and 70: anti-apoptotic proteins with tumorigenic properties. Cell Cycle 2006, 5(22), 2592-2601 (Pubitemid 44785803)
13. Multhoff, G.; Botzler,C.; Jennen, L.; Schmidt, J.; Ellwart, J.; Issels, R. Heat shock protein 72 on tumor cells. J Immunol 1997, 158(9), 4341-4350.
14. Uozaki, H.; Horiuchi, H.; Ishida, T.; Iijima, T.; Imamura, T.; Machinami, R.. Overexpression of resistance-related proteins (metallothioneins, glutathione-S-transferase pi, heat shock protein 27, and lung resistance-related protein) in osteosarcoma. Relationship with poor prognosis. Cancer 1997, 79(12), 2336-2344. (Pubitemid 27251016)
15. Trieb, K.; Lechleitner, T.; Lang, S.; Windhager, R.; Kotz, R.; Dirnhofer, S. Heat shock protein 72 expression in osteosarcomas correlates with good response to neoadjuvant chemotherapy. Hum Pathol 1998, 29(10), 1050-1055. (Pubitemid 28467522)
16. Yonally, S.K.; Capaldi, R.A. The F(1)F(0) ATP synthase and mitochondrial respiratory chain complexes are present on the plasma membrane of an osteosarcoma cell line: An immunocytochemical study. Mitochondrion 2006, 6(6), 305-314.
17. Ristow, M. Oxidative metabolism in cancer. Curr Opin Clin Nutr Metab Care 2006, 9(4), 339-345.
18. Feng, Y.; Tian, Z.M.; Wan, M.X.; Zheng, Z.B. Protein profile of human hepatocarcinoma cell line SMMC-7721: identification and functional analysis. World J Gastroenterol 2007, 13(18), 2608-2614.
19. Amaar, Y.G.; Baylink, D.J.; Mohan, S. Ras-association domain family 1 protein, RASSF1C, is an IGFBP-5 binding partner and a potential regulator of osteoblast cell proliferation. J Bone Miner Res 2005, 20(8), 1430-1439. (Pubitemid 41033527)
20. Bihani, T.; Mason, D.X.; Jackson, T.J.; Chen, S.C.; Boettner, B.; Lin, A.W. Differential oncogenic ras signaling and senescence in tumor cells. Cell Cycle 2004, 3(9), 1201-1207.
21. Canton, D.A.; Olsten, M.E.; Kim, K.; Doherty-Kirby, A.; Lajoie, G.; Cooper, J.A.; Litchfield, D.W. The pleckstrin homology domain-containing protein CKIP-1 is involved in regulation of cell morphology and the actin cytoskeleton and interaction with actin capping protein. Mol Cell Biol 2005, 25(9), 3519-3534.
22. Toretsky, J.; Levenson, A.; Weinberg, I.N.; Tait, J.F.; Uren, A.; Mease, R.C. Preparation of F-18 labeled annexin V: a potential PET radiopharmaceutical for imaging cell death. Nucl Med Biol 2004, 31(6), 747-752.
23. Wang, S.; Nath, N.; Adlam, M.; Chellappan, S. Prohibitin, a potential tumor suppressor, interacts with RB and regulates E2F function. Oncogene 1999, 18(23), 3501-3510.
24. Manjeshwar, S.; Branam, D.E.; Lerner, M.R.; Brackett, D.J.; Jupe, E.R. Tumor suppression by the prohibitin gene 3′ untranslated region RNA in human breast cancer. Cancer Res 2003, 63(17), 5251-5256.
25. Sato, T.; Sakamoto, T.; Takita, K.; Saito, H.; Okui, K.; Nakamura, Y. The human prohibitin (PHB) gene family and its somatic mutations in human tumors. Genomics 1993, 17(3), 762-764. (Pubitemid 23282837)
26. Hibi, K.; Liu, Q.; Beaudry, G.A.; Madden, S.L.; Westra,W.H.; Wehage, S.L.; Yang, S.C.; Heitmiller, R.F.; Bertelsen, A.H.; Sidransky, D.; Jen, J. Serial analysis of gene expression in non-small cell lung cancer. Cancer Res 1998, 58(24), 5690-5694. (Pubitemid 29006407)
27. Fujii, J.; Ikeda, Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 2002, 7(3), 123-130. (Pubitemid 34700435)
28. Jang, J.S.; Cho, H.Y.; Lee, Y.J.; Ha, W.S.; Kim, H.W. The differential proteome profile of stomach cancer: identification of the biomarker candidates. Oncol Res 2004, 14(10), 491-499.
29. Karihtala, P.; Mantyniemi, A.; Kang, S.W.; Kinnula, V.L.; Soini, Y. Peroxiredoxins in breast carcinoma. Clin Cancer Res 2003, 9(9), 3418-3424.